My research examines how mitochondrial therapeutics can improve muscle strength and size in Duchenne muscular dystrophy, a fatal disease that prevents individuals from exercising. The goal of my research is to translate what is learned from pre-clinical models to inform physicians, patients and decision makers on avenues that will best improve life in people with muscular dystrophies.